Patent Assignment
Reel/Frame 060979/0299
Assignment of Assignor's Interest
Recorded: 2022-09-02
Pages: 5
Assignor
SHIRE HUMAN GENETIC THERAPIES, INC.
Executed: 2021-02-26
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, JAPAN
Covered Property
(1)
Inhibitors of Plasma Kallikrein and Uses Thereof
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 2, 2022
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 060979/0113 →
Assignment of Assignor's Interest
Sep 2, 2022
From: RAE, ALASTAIR; ELLARD, JOHN MARK
To: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
Reel/Frame 060979/0188 →
Assignment of Assignor's Interest
Sep 2, 2022
From: PAPAIOANNOU, NIKOLAOS; MILLER, THOMAS ALLEN; SHIPPS, GERALD WAYNE, JR.; TRAVINS, JEREMY MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060979/0211 →
Assignment of Assignor's Interest
Sep 2, 2022
From: BIODURO LLC
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060979/0247 →
Assignment of Assignor's Interest
Sep 2, 2022
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 060979/0293 →
Assignment of Assignor's Interest
Sep 2, 2022
From: CHARLES RIVER LABORATORIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060979/0360 →